SWOG 1800D

Primary Category:

Treatment Protocols

Disease Category:

Lung, Lung - Non-Small Cell Metastatic

Status:

New, Open

A Phase II/III Study of N-803 (ALT-803) Plus Pembrolizumab Versus Standard of Care in Participants with Stage IV or Recurrent Non-Small Cell Lung Cancer Previously Treated with Anti-PD-1 or Anti-PD-L1 Therapy (Lung-MAP Non-Match Sub-Study)

NCT#05096663